[A new therapy of hepatic insufficiency. Experiments with (+)-3--cyanidanol. Its importance in the treatment of alcoholic hepatitis].
D000328:Adult; D000368:Aged; D001578:Benzopyrans / Q000627:therapeutic use*; D002392:Catechin / Q000627:therapeutic use*; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005234:Fatty Liver / Q000188:drug therapy; D005260:Female; D006505:Hepatitis / Q000188:drug therapy; D006509:Hepatitis B / Q000188:drug therapy; D006519:Hepatitis, Alcoholic / Q000188:drug therapy*; D006801:Humans; D008104:Liver Cirrhosis, Alcoholic / Q000188:drug therapy; D008107:Liver Diseases / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
D001578:Benzopyrans; D002392:Catechin
Una nuova terapia dell'insufficienza epatica. Sperimentazione del (+)-cyanidanol-3. Suo interesse nel trattamento dell'epatite alcoolica.